4D MOLECULAR THERAPEUTICS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for 4D MOLECULAR THERAPEUTICS IN COM, CUSIP 35104E950.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for 4D MOLECULAR THERAPEUTICS IN COM, CUSIP 35104E950.